stockrowMobia Medical, Inc
MOBI Healthcare Medical Devices
Mobia Medical, Inc’s revenue for fiscal 2025 (year ended December 2025) was $32.0 million, up 104.8% from fiscal 2024.
- Revenue
- +175.9%
- EPS
- +96.0%
- Free cash flow
- −18.0%
Quarter to September 2026, against a year earlier
Follow MOBI
Alert me
Mobia Medical, Inc (MOBI) Piotroski F-score
Mobia Medical, Inc's Piotroski F-score for fiscal 2025 cannot be worked out: needs three fiscal years.
Piotroski F-score, annual
Annual newest first
| Period | Piotroski F-score | Change (points) |
|---|
How fiscal 2025’s score is made up
| Test | This year | Year before | Result | Points |
|---|---|---|---|---|
| Positive return on assets | (132.40%) | — | Fail | 0 |
| Positive operating cash flow | (45.69m) | (24.32m) | Fail | 0 |
| Rising return on assets | (132.40%) | — | n/a | — |
| Cash flow above net income | 803.20k | 287.70k | Pass | 1 |
| Falling long-term leverage | 0.20 | — | n/a | — |
| Rising current ratio | 4.54 | 4.61 | Fail | 0 |
| No new shares issued | 849,000 | 575,000 | Fail | 0 |
| Rising gross margin | 81.07% | 79.59% | Pass | 1 |
| Rising asset turnover | 0.91 | — | n/a | — |
| Piotroski F-score | n/a — needs three fiscal years | — | ||
How the Piotroski F-score works
One point for each of nine tests, this fiscal year against the one before: positive return on assets, positive operating cash flow, rising return on assets, cash flow above net income, falling long-term leverage, a rising current ratio, no new shares issued, a rising gross margin and rising asset turnover. The ratios are the ones on this site, so each can be checked.
Joseph Piotroski (2000) called 8–9 high and 0–1 low; reading it in three bands is the common convention:
| 7–9 | Strong — most fundamentals improved |
|---|---|
| 4–6 | Mixed |
| 0–3 | Weak — most fundamentals deteriorated |
Where this differs from the paper: return on assets is on average rather than beginning-of-year assets, and weighted basic shares stand in for shares issued. The score is shown only when all nine tests can be worked out, which takes three fiscal years; banks and insurers, which report no current assets or gross profit, have none.
Piotroski F-score against peers
| Company | Piotroski F-score |
|---|---|
| BWAY Brainsway Ltd. Sponsored ADR compare | 6 |
| VMD Viemed Healthcare, Inc. compare | 5 |
| SSII SS Innovations International, Inc. compare | 5 |
| OFIX ORTHOFIX MEDICAL INC. compare | 5 |
| CLPT ClearPoint Neuro, Inc. compare | 4 |
| RCEL Avita Medical Inc. compare | 3 |
| SI Shoulder Innovations, Inc. compare | — |
| MOBI Mobia Medical, Inc | — |
| CV CapsoVision, Inc. compare | — |
What Piotroski F-score is
The Piotroski F-Score tells an investor how many signs of improving profitability, funding and efficiency a company shows against a year earlier.
One point for each of nine tests against a year earlier: positive return on assets, positive operating cash flow, rising return on assets, cash flow above net income, falling long-term leverage, rising current ratio, no new shares issued, rising gross margin, and rising asset turnover